Act Two Investors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.93M Sell
11,965
-88
-0.7% -$31.6K 0.87% 21
2025
Q4
$4.24M Sell
12,053
-2,128
-15% -$775K 0.76% 23
2025
Q3
$5.24M Sell
14,181
-424
-3% -$164K 0.93% 23
2025
Q2
$5.78M Sell
14,605
-222
-1% -$83K 1.18% 19
2025
Q1
$5.52M Sell
14,827
-273
-2% -$104K 1.17% 20
2024
Q4
$5.44M Sell
15,100
-524
-3% -$194K 1.06% 20
2024
Q3
$5.64M Sell
15,624
-1,379
-8% -$476K 1.06% 19
2024
Q2
$5.79M Sell
17,003
-597
-3% -$202K 1.15% 17
2024
Q1
$6.3M Sell
17,600
-84
-0.5% -$28.3K 1.27% 18
2023
Q4
$5.3M Buy
17,684
+532
+3% +$149K 1.14% 19
2023
Q3
$4.69M Hold
17,152
1.25% 19
2023
Q2
$5.23M Buy
17,152
+1,042
+6% +$301K 1.46% 17
2023
Q1
$4.6M Buy
16,110
+6,136
+62% +$1.63M 1.83% 13
2022
Q4
$2.44M Buy
9,974
+56
+0.6% +$12.7K 2.52% 15
2022
Q3
$2.01M Buy
+9,918
New +$2.09M 2.03% 16

Other funds holding SYK

Act Two Investors's SYK Position: Q1 2026 in Review

Act Two Investors reduced its Stryker (SYK) stake by 0.73% in Q1 2026, selling an estimated $31.6K and leaving 11,965 shares worth $3.93M. The position accounts for 0.87% of the portfolio, ranked #21.

Act Two Investors first reported a position in SYK in Q3 2022 and has held it in 15 quarters since. The position peaked at $6.3M in Q1 2024. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Act Two Investors held 11,965 shares of Stryker worth $3.93M as of Q1 2026.
  • Act Two Investors sold 88 Stryker shares in Q1 2026, an estimated $31.6K.
  • Stryker made up 0.87% of Act Two Investors's portfolio in Q1 2026, its #21 holding.
  • Act Two Investors first reported a position in Stryker in Q3 2022 and has held it in 15 quarters since.
  • Act Two Investors's Stryker position peaked at $6.3M in Q1 2024.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Act Two Investors's 13F filing for Q1 2026, filed 8 May 2026.